Peer Review reports
From: Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
| Original Submission | ||
|---|---|---|
| 1 Oct 2020 | Submitted | Original manuscript |
| 19 Oct 2020 | Reviewed | Reviewer Report - Michiel A.J. van de Sande |
| 4 Nov 2020 | Reviewed | Reviewer Report |
| 15 Nov 2020 | Author responded | Author comments - Emanuela Palmerini |
| Resubmission - Version 2 | ||
| 15 Nov 2020 | Submitted | Manuscript version 2 |
| 18 Nov 2020 | Reviewed | Reviewer Report - Michiel A.J. van de Sande |
| 22 Nov 2020 | Reviewed | Reviewer Report |
| 7 Dec 2020 | Author responded | Author comments - Emanuela Palmerini |
| Resubmission - Version 3 | ||
| 7 Dec 2020 | Submitted | Manuscript version 3 |
| 10 Dec 2020 | Author responded | Author comments - Emanuela Palmerini |
| Resubmission - Version 4 | ||
| 10 Dec 2020 | Submitted | Manuscript version 4 |
| Publishing | ||
| 15 Dec 2020 | Editorially accepted | |
| 22 Jan 2021 | Article published | 10.1186/s12885-020-07739-8 |
You can find further information about peer review here.